Cite

HARVARD Citation

    Hahn, A. et al. (2020). Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials. ESMO open. 5 (6), p. . [Online]. 
  
Back to record